The role of the fat mass and obesity associated gene (FTO) in breast cancer risk

• Published in: BMC medical genetics Vol. 12; no. 1; p. 52
• Main Authors: Kaklamani, Virginia, Yi, Nengjun, Sadim, Maureen, Siziopikou, Kalliopi, Zhang, Kui, Xu, Yanfei, Tofilon, Sarah, Agarwal, Surbhi, Pasche, Boris, Mantzoros, Christos
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 13.04.2011; BioMed Central; BMC
• Subjects: Adipose tissues; Adult; Aged; Aged, 80 and over; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Breast cancer; Breast Neoplasms - genetics; Breast Neoplasms - pathology; Female; Genetic aspects; Genome-Wide Association Study; Genotype; Humans; Introns; Middle Aged; Obesity; Odds Ratio; Polymorphism, Single Nucleotide; Proteins - genetics; Proteins - physiology; Risk; Risk factors; Illinois
• ISSN: 1471-2350; 1471-2350
• DOI: 10.1186/1471-2350-12-52

Obesity has been shown to increase breast cancer risk. FTO is a novel gene which has been identified through genome wide association studies (GWAS) to be related to obesity. Our objective was to evaluate tissue expression of FTO in breast and the role of FTO SNPs in predicting breast cancer risk. We performed a case-control study of 354 breast cancer cases and 364 controls. This study was conducted at Northwestern University. We examined the role of single nucleotide polymorphisms (SNPs) of intron 1 of FTO in breast cancer risk. We genotyped cases and controls for four SNPs: rs7206790, rs8047395, rs9939609 and rs1477196. We also evaluated tissue expression of FTO in normal and malignant breast tissue. We found that all SNPs were significantly associated with breast cancer risk with rs1477196 showing the strongest association. We showed that FTO is expressed both in normal and malignant breast tissue. We found that FTO genotypes provided powerful classifiers to predict breast cancer risk and a model with epistatic interactions further improved the prediction accuracy with a receiver operating characteristic (ROC) curves of 0.68. In conclusion we have shown a significant expression of FTO in malignant and normal breast tissue and that FTO SNPs in intron 1 are significantly associated with breast cancer risk. Furthermore, these FTO SNPs are powerful classifiers in predicting breast cancer risk.